<DOC>
	<DOCNO>NCT00141648</DOCNO>
	<brief_summary>This trial intend determine result obtain standard treatment Non Hodgkin 's lymphoma apply disease rare subtype arise bone . Patients study undergo detailed assessment , treatment chemotherapy radiotherapy , follow close monitoring .</brief_summary>
	<brief_title>Chemotherapy Radiotherapy Osteolymphoma</brief_title>
	<detailed_description>Patients non-Hodgkin 's lymphoma arise primarily bone study use number different name make literature search difficult . The term Osteolymphoma propose make search easy future . Patients study undergo stag include isotope bone scan PET scan available . Eligible patient undergo treatment three cycle CHOP chemotherapy conventional dos shrink field radiotherapy total 45 Gy . Monoclonal antibody include good result obtain without use . After treatment patient regularly monitor . The trial present twice per year meeting TROG , ALLG AROLG .</detailed_description>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<criteria>Histologically confirm nonHodgkin 's lymphoma bony site Limited extraosseous disease Ann Arbor stage IE Age &gt; 17 ECOG performance status &lt; 3 Expected survival &gt; 6 month Patients capable childbearing use adequate contraception . Written inform consent Previous radiotherapy Previous malignancy Medically unfit undergo treatment</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Osteolymphoma</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Lymphoma</keyword>
</DOC>